Patient Power®
Get Email Alerts!
Health Topics
Lymphoma Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2011
    • Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    Spring Survey 2012 Results

    News on Lymphoma from 2007 ASCO and Pan Pacific Conference

    PROGRAM DETAILS:

    Lymphomas account for about five percent of all cases of cancer in the United States, and it is the most common form of blood cancer. It affects many people, which is why it is important to know about the latest treatments and news related to this disease. In this first edition of Patient Power’s Special Edition Lymphoma Series, Dr. Julie Vose joins Andrew Schorr to discuss news from the latest American Society of Clinical Oncology (ASCO) meeting and the Pan Pacific Lymphoma Conference. Dr. Vose is professor of Internal Medicine at the University of Nebraska’s Hematology and Oncology Section and a renowned expert in Lymphoma.

    In this broadcast you’ll hear Dr. Vose talk about the exciting news and data that has come from these meetings, including improvements in current therapies, genetic analysis of lymphoma and new agents currently being studied, such as bortezomib or Velcade. She goes into detail discussing CHOP-R treatment, various chemotherapy drugs and novel agents on the horizon. Andrew asks about lymphoma vaccines, and Dr. Vose explains how these trials works and the status of some particular studies. Dr. Vose answers a variety of listener questions addressing a number of topics, including: the effect of chemotherapy on pregnancy; why the incidence of lymphoma is on the rise; side effects of medicines; when to begin treatment; and how to proceed with treatment when others have failed. She details the various stages of lymphoma and how interferon treatment is used to treat other diseases and the effect this may have on you.

    Also included in the interview is a conversation about participating in clinical trials and the benefits of being treated at an academic medical or research center. Dr. Vose addresses the importance of studying and treating cases of lymphoma in an individualized and personal manner. She speaks candidly about the future of lymphoma treatment, with a focus on genetic analysis and finding less toxic treatment options. If you or someone you know is affected by lymphoma, this program is sure to leave you with an optimistic outlook.

    Get Email Updates:

    Get updated automatically when new content about Lymphoma has been posted.
    Privacy Policy
    Lymphoma
    EXPERTS & GUESTS:
    Julie Vose, M.D.
    Chief of the Oncology/Hematology Section in the Department of Internal Medicine, University of Nebraska Medical Center
    Julie Vose, M.D. is the Neumann M. and Mildred E. Harris Professorial Chair and is the current Chief of the Oncology/Hematology Section in the Department of Internal Medicine at University of Nebraska Medical Center (UNMC). She received all of her medical education and training at UNMC and has been a member of the faculty since 1990. Dr. Vose is an... more >

    TRANSCRIPT:

    1. Introduction
    2. New Lymphoma Treatment
    3. Novel Agents on the Horizon
    4. Treating Individual Lymphomas
    5. Lymphoma Vaccines
    6. Clinical Trials and Research Centers
    7. Interferon Treatment and Other Diseases
    8. Chemotherapy and Pregnancy
    9. Treatments for Mantle Cell Lymphoma
    10. Stages of Lymphoma
    11. The Future of Lymphoma Treatment
    12. Dealing with Nausea

    RELATED LINKS: